Investor Type | Firm |
Industries | Software (Web Marketplace Saas..) • Media • BioTech • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) |
Stages | Acquisition |
Investing | Netherlands |
Investment Range | $268,800,000 - $268,800,000 |
Norgine is a pharmaceutical company which develops, produces and markets pharmaceutical products in Western Europe. The company seeks to strengthen and expand its core business through acquisitions. It was founded in 1906 and is headquartered in Amsterdam, Netherlands.